CD274 and neoplasm: Despite its daily use in the clinic, IHC-based TPS suffers from several fundamental limitations, caused by variations in PD-L1 monoclonal antibodies and staining intensity, heterogeneous PD-L1 expression throughout tumors4,5, and the intrinsic limitation of the human visual capability to detect, classify and quantify thousands of tumor cells in histopathology slides6.